Who is eligible for clinical trial NCT02775643?

Participants must meet protocol criteria for Melanoma. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT02775643 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2025-11-06

Molecular Analysis of Childhood and Adolescent Melanocytic Lesions (NCT02775643)

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: St. Jude Children's Research Hospital

🩺 Plain-English Summary (8th-Grade Level)

This is an observational, non-therapeutic study to collect clinical and molecular information of pediatric patients with childhood melanocytic lesions. PRIMARY OBJECTIVE: To perform a comprehensive molecular analysis of samples either from paraffin embedded and/or frozen tissue from patients with pediatric melanocytic lesions (including melanoma, spitzoid melanoma, congenital melanoma, melanoma arising in giant nevi). SECONDARY OBJECTIVE: To collect minimal information on patients treated with adjuvant or systemic therapies according to National Comprehensive Cancer Network (NCCN) guidelines.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (9 items) and avoid the listed exclusions (4 items).

Location: St. Jude Children's Research Hospital — Memphis, Tennessee

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Participant has a suspected or confirmed diagnosis of a melanocytic lesion, including:
Conventional or "adult-type" melanoma
Spitzoid melanoma/atypical Spitz tumor
Congenital melanoma
Melanoma arising in a giant congenital nevus
Melanocytic lesions with indeterminate biological behavior (e.g., pigment synthesizing melanomas)
Participant was \<19 years of age at the time of diagnosis.
Tissue is available for biologic studies.
Participant has been enrolled on the TBANK protocol at SJCRH, or will be enrolled before any research tests are performed on their biological materials.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Ocular melanoma
Inability or unwillingness of research participant or legal guardian to consent.
Histologic diagnosis other than melanocytic lesion described in 3.1.1.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

St. Jude Children's Research Hospital — Memphis, Tennessee

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗